Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Moodys
AstraZeneca
Harvard Business School
Mallinckrodt
Boehringer Ingelheim

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

PHOTOFRIN Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Photofrin, and what generic alternatives are available?

Photofrin is a drug marketed by Concordia Labs Inc and is included in one NDA.

The generic ingredient in PHOTOFRIN is porfimer sodium. One supplier is listed for this compound. Additional details are available on the porfimer sodium profile page.

Summary for PHOTOFRIN
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Clinical Trials: 23
DailyMed Link:PHOTOFRIN at DailyMed
Drug patent expirations by year for PHOTOFRIN
Recent Clinical Trials for PHOTOFRIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1
Concordia Laboratories Inc.Phase 1
University of PennsylvaniaPhase 2

See all PHOTOFRIN clinical trials

Pharmacology for PHOTOFRIN
Drug ClassPhotoactivated Radical Generator
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity

US Patents and Regulatory Information for PHOTOFRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PHOTOFRIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Dow
Harvard Business School
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.